This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MDRP 2022 — Medicaid Drug Rebate Program Summit
Delivered as a Hybrid Event October 11-13th, 2022
In-Person October 11-13Chicago, IL

Ronald Sargent, MBA
National Accounts Director at GlaxoSmithKline US


Ronald Sargent, MBA, is National Accounts Director, GPOs for GlaxoSmithKline (GSK), where he has worked for 29 years. Before assuming this role, he led contracting teams within GSK focused on the vaccines business. He has in-depth knowledge of the vaccines commercial landscape, including buy and bill, VFC, and public health models.

Mr. Sargent has more than 25 years of experience leading teams within the IDN, federal/DoD, public health, and hospital markets. His background has also included commercial roles within GSK and previously at Wyeth in vaccines, neurology, oncology, respiratory, and specialty pharmaceuticals.

Mr. Sargent holds a BS in economics from United States International University and an MBA from the University of San Diego.

Agenda Sessions

  • The Role of HRSA's 340B Prime Vendor


Speakers at this event